Diagnosis and treatment of Wilson's disease

被引:39
作者
Brewer, GJ
Fink, JK
Hedera, P
机构
[1] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[4] Ann Arbor Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA
关键词
Wilson's disease; neurological disease; liver disease; ATP7B; copper;
D O I
10.1055/s-2008-1040842
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Wilson's disease is due to an inherited defect in copper excretion into the bile by the liver. The resulting copper accumulation and copper toxicity results in liver disease, and in some patients, brain damage. Patients present, generally between the ages of 10 and 40 years, with liver disease, neurological disease of a movement disorder type, or behavioral abnormalities, and often with a combination of these. Because Wilson's disease is effectively treated, it is extremely important for physicians to learn to recognize and diagnose the disease. Treatment options have evolved rapidly in the last few years, with zinc now being the drug of choice in most situations.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 66 条
[1]  
BARBEAU A, 1970, LANCET, V1, P1180
[2]   COPPER-METABOLISM IN RATS GIVEN DITHIOMOLYBDATES OR TRITHIOMOLYBDATES [J].
BREMNER, I ;
MILLS, CF ;
YOUNG, BW .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1982, 16 (02) :109-119
[3]   TREATMENT OF WILSONS-DISEASE WITH AMMONIUM TETRATHIOMOLYBDATE .1. INITIAL THERAPY IN 17 NEUROLOGICALLY AFFECTED PATIENTS [J].
BREWER, G ;
DICK, RD ;
JOHNSON, V ;
WANG, YX ;
YUZBASIYANGURKAN, V ;
KLUIN, K ;
FINK, JK ;
AISEN, A .
ARCHIVES OF NEUROLOGY, 1994, 51 (06) :545-554
[4]  
BREWER G J, 1990, Journal of Trace Elements in Experimental Medicine, V3, P227
[5]   Treatment of Wilson's disease with zinc .14. Studies of the effect of zinc on lymphocyte function [J].
Brewer, GJ ;
Johnson, V ;
Kaplan, J .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 129 (06) :649-652
[6]   TREATMENT OF WILSONS-DISEASE WITH ZINC-XII - DOSE REGIMEN REQUIREMENTS [J].
BREWER, GJ ;
YUZBASIYANGURKAN, V ;
JOHNSON, V ;
DICK, RD ;
WANG, YX .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 305 (04) :199-202
[7]   INITIAL THERAPY OF PATIENTS WITH WILSONS-DISEASE WITH TETRATHIOMOLYBDATE [J].
BREWER, GJ ;
DICK, RD ;
YUZBASIYANGURKIN, V ;
TANKANOW, R ;
YOUNG, AB ;
KLUIN, KJ .
ARCHIVES OF NEUROLOGY, 1991, 48 (01) :42-47
[8]  
BREWER GJ, 1991, J LAB CLIN MED, V118, P466
[9]   Treatment of Wilson disease with ammonium tetrathiomolybdate .2. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy [J].
Brewer, GJ ;
Johnson, V ;
Dick, RD ;
Kluin, KJ ;
Fink, JK ;
Brunberg, JA .
ARCHIVES OF NEUROLOGY, 1996, 53 (10) :1017-1025
[10]  
BREWER GJ, 1989, J LAB CLIN MED, V114, P633